TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling

Camilla Heiniö1, Riikka Havunen2, Joao Santos1,2

  • 1Cancer Gene Therapy Group, Faculty of Medicine, TRIMM, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland.

Cells
|April 1, 2020
PubMed

Insights

This study reveals that a novel oncolytic adenovirus, OAd.TNFa-IL2, activates the AIM2 inflammasome. This activation enhances the anti-tumor immune response, offering a new strategy to overcome tumor resistance.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Tumor resistance to traditional treatments necessitates novel therapeutic strategies.
  • Oncolytic viruses are engineered to selectively infect and kill cancer cells.
  • Pattern recognition receptors (PRRs) mediate cellular responses to viral infections, influencing treatment outcomes.

Purpose of the Study:

  • To investigate the effects of the cytokine-armed oncolytic adenovirus OAd.TNFa-IL2 on PRR-mediated signaling.
  • To determine which PRRs are crucial for mediating an anti-tumor response to OAd.TNFa-IL2 virotherapy.
  • To understand how OAd.TNFa-IL2 modulates the tumor microenvironment through PRR activation.

Main Methods:

  • Treatment of tumor models with OAd.TNFa-IL2 (TILT-123).
  • Analysis of danger-associated molecular pattern (DAMP) and pathogen-associated molecular pattern (PAMP) release.
  • Assessment of PRR activation, specifically the AIM2 inflammasome.
  • Evaluation of tumor microenvironment changes and anti-tumor immune responses.

Main Results:

  • OAd.TNFa-IL2 infection induced significant DAMP and PAMP release.
  • The AIM2 inflammasome was demonstrably activated following OAd.TNFa-IL2 treatment.
  • This activation led to a modulation of the tumor microenvironment, creating an immunostimulatory milieu.
  • PRR signaling was identified as a key mediator of the anti-tumor effects.

Conclusions:

  • OAd.TNFa-IL2 effectively breaks tumor resistance by activating PRR-mediated pathways.
  • AIM2 inflammasome activation is a critical mechanism driving the anti-tumor immune response in OAd.TNFa-IL2 virotherapy.
  • Targeting PRR signaling presents a promising avenue for optimizing oncolytic virus therapy.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K